Speaking to pharmaphorum on a recent flying visit to London from Celgene's European HQ in Boudry, Switzerland, Pätsi laid out the company's plans for the next few years. Three approvals in three ...
Celgene has today confirmed that it will acquire Juno Therapeutics for $9 billion, and says the move will make it a leader in cell immunotherapy. The price is a significant premium on the $5.5 bn ...
La fin d’une vacance au Conseil communal de Boudry se précise. Les socialistes proposent Mallorie Schlaeppi pour succéder à la démissionnaire Rita Piscopiello. Le Conseil général se ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback